Agency / Source: Becton, Dickinson and Company

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care - BD Awarded $100 Million Contract for Enterprise-Wide Automated Medication Dispensing Across 115 Military Health Facilities - BD.com
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care

 

PRZOOM - /newswire/ - Franklin Lakes, NJ, United States, 2017/03/01 - BD Awarded $100 Million Contract for Enterprise-Wide Automated Medication Dispensing Across 115 Military Health Facilities - BD.com. NYSE: BDX

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

BD (Becton, Dickinson and Company), a leading global medical technology company, today announced that it was awarded a contract worth up to $100 million with the Defense Health Agency (DHA) under the U.S. Department of Defense (DoD) for its Pyxis™ ES System. Under the purchase agreement, BD will provide its enterprise-wide medication dispensing technology platform across the DHA’s 115 military inpatient health facilities and military inpatient pharmacies.

“Through this collaboration with the DoD, we have the opportunity to help modernize the DHA’s medication management and dispensing systems across all of the organization’s facilities in the United States, Asia and Europe,” said Ranjeet Banerjee, worldwide president of Medication Management for BD. “We are honored to expand our longstanding partnership with the organization, to both upgrade existing legacy Pyxis sites to an enterprise-wide solution, as well as expand our footprint across all DHA facilities.”

Key solution areas include:

• The Pyxis ES System’s Automated Dispensing Cabinet (ADC) meets the highest quality standards for implementation at military treatment facilities across the Military Health System;
• Proven pharmacy inpatient automation solution with flexibility to handle multiple architecture configurations supporting decentralized deployments;
• Flexibility to consolidate configurations and scale the system via a centralized enterprise-wide platform;
• Secure storage of medication and pharmaceutical items;
• Provides automated system administration with tracking and management of medications;
• Provides advanced data analytics and reporting capabilities;
• Supports industry standard interface and integration capabilities and compatibilities.

Under the terms of the agreement, BD will provide its industry leading Pyxis ES System consisting of Pyxis™ Enterprise Server, Pyxis MedStation™ ES system, Pyxis™ Smart CUBIE™ technology, and integrated analytics tools the Knowledge Portal for Pyxis™ medication technologies. This contract award is contemplated in the company’s fiscal year 2017 guidance.

The Pyxis ES System is a scalable, web-based platform specifically designed to improve medication management across the continuum of care. The Pyxis ES platform promotes a patient-centric health care model, leveraging HIT system and Active Directory integration to enable a single health system formulary, simplified identity management and workflow enhancements. The platform enables pharmacists to manage medications remotely and eliminate redundant tasks. Nurses can readily access secured medications using safe and simple workflows that are centered on the patient.

For more information about the Pyxis Enterprise Solution, please visit carefusion.com/pyxis.

About BD
BD (bd.com) is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 40,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health.

BD Contact: Monique N. Dolecki - BD Investor Relations
P: 201 847 5378 - E: monique_dolecki[.]bd.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Becton, Dickinson and Company

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
BD | Pyxis™ ES System
Contact: Matthew Coppola - BD.com 
201-847-7370 matthew_r_coppola[.]bd.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Becton, Dickinson and Company securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From Becton, Dickinson and Company / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Press Releases:

South Carolina-based IMCS Awarded Major NIH Research Grant
Preventive Healthcare Measures to Combat Obesity and Lifestyle Diseases Steer Demand for Nutritional Lipids Globally Finds Frost & Sullivan
Covance, LabCorp’s Drug Development Business, Acclaimed by Frost & Sullivan for its Unmatched Breadth of Services to Support Clinical Trials
Clariant Lauded by Frost & Sullivan for Addressing the Growing Customer Demand for Natural Anti-aging Active Ingredients with its Product, Prenylium®
Guardant Health AMEA Wins Frost & Sullivan’s Market Leadership Award for Liquid Biopsy in Precision Oncology in Asia, Middle East and Africa
Global Biosimilars Market Poised to Grow At Chart-topping Levels with a CAGR of 17.3%, Reaching .2 Billion by 2026 Finds Frost & Sullivan
Technological Advancements in Manufacturing Boost the Cell and Gene Therapy Market Says Frost & Sullivan
Huami Corp and Royal DSM Announce Collaboration on Wearable Technologies and Health Tracking for Personalized Nutrition
DSM Expands Animal Nutrition & Health Operations in China with Opening of Seventh Premix Plant
Biosurfactants and Natural Preservatives Drive Innovation for Functional Ingredients in Personal Care Market Finds Frost & Sullivan

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  iBet.ag

Visit  BizJobs.com

Visit  Limelon Advertising, Co.







 
  ©2021 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today